Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors.
Meeting Abstract
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Sonpavde, Guru P.; Call, Justin A.; Falchook, Gerald Steven; Garmezy, Benjamin; Rasco, Drew W.; Liu, Lan; Niu, Tiantian; He, Jenna; Zhang, Congcong; Kochan, Jarema; Rebello, Sam; Russo, Giuseppe; Chen, Viola; Krishnan, Suba
Publication Date
June 1, 2024
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
Additional Document Info
volume
42
issue
16